4-butyrolactone has been researched along with Aging in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, WW; Dai, Z; Li, BY; Liu, HF; Liu, XQ; Luo, Y; Pan, HF; Wang, H; Wang, Q; Wei, SF; Xu, TT; Zhang, SJ; Zheng, JY; Zhu, WL | 1 |
| Chen, C; Chen, YS; Du, JR; He, Q; Kuang, X; Li, LJ; Li, YJ; Liu, K; Wang, LF; Wang, Y; Zhang, MX | 1 |
| Hummel, T; Puschmann, L; Sinding, C | 1 |
| Feng, ZB; Li, JJ; Lu, YP; Qian, ZM; Zhao, P; Zhu, L; Zhu, Q | 1 |
| Joubert, KE | 1 |
| Adlercreutz, H; Hallmans, G; Hultén, K; Johansson, R; Lenner, P; Winkvist, A | 1 |
| Beales, M; Lorden, JF; McKeon, TW; Oltmans, GA; Walkley, SU | 1 |
| Sokoloff, L | 1 |
| Dendel, PS; Shalaby, IA; Spear, LP | 1 |
| Brüggemann-Rotgans, IE; Kardinaal, AF; Morton, MS; van Beresteijn, EC | 1 |
| Chung, BC; Huh, KB; Kim, MK; Lee, HC; Lim, SK; Nam, JH; Yu, VY | 1 |
| Scalzo, FM; Spear, LP | 1 |
1 review(s) available for 4-butyrolactone and Aging
| Article | Year |
|---|---|
Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose.
Topics: 4-Butyrolactone; Aging; Animals; Auditory Diseases, Central; Autoradiography; Blood Glucose; Blood-Brain Barrier; Brain; Carbon Radioisotopes; Cats; Central Nervous System; Cerebrovascular Circulation; Deoxy Sugars; Deoxyglucose; Dogs; Electrophysiology; Energy Metabolism; Humans; Macaca mulatta; Morphine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sciatic Nerve; Seizures; Thiopental; Visual Cortex | 1981 |
1 trial(s) available for 4-butyrolactone and Aging
| Article | Year |
|---|---|
The effects of firocoxib (Previcox) in geriatric dogs over a period of 90 days.
Topics: 4-Butyrolactone; Aging; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Chemical Analysis; Dog Diseases; Dogs; Female; Lameness, Animal; Male; Osteoarthritis; Pain; Severity of Illness Index; Sulfones; Treatment Outcome | 2009 |
10 other study(ies) available for 4-butyrolactone and Aging
| Article | Year |
|---|---|
Ligustilide improves aging-induced memory deficit by regulating mitochondrial related inflammation in SAMP8 mice.
Topics: 4-Butyrolactone; Aging; Animals; Apoptosis; Brain; Inflammation; Male; Maze Learning; Memory Disorders; Mice; Mitochondria; Neuroprotective Agents; Oxidative Stress; Spatial Memory | 2020 |
Klotho upregulation contributes to the neuroprotection of ligustilide in an Alzheimer's disease mouse model.
Topics: 4-Butyrolactone; Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cells, Cultured; Disease Models, Animal; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression Regulation, Developmental; Glucuronidase; Insulin-Like Growth Factor I; Klotho Proteins; Male; Memory Disorders; Mice; Mice, Inbred Strains; Molecular Targeted Therapy; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Phosphorylation; Signal Transduction; tau Proteins; Up-Regulation | 2014 |
Is the age-related loss in olfactory sensitivity similar for light and heavy molecules?
Topics: 4-Butyrolactone; Adolescent; Adult; Aged; Aging; Female; Humans; Lactones; Male; Middle Aged; Odorants; Olfaction Disorders; Olfactory Receptor Neurons; Sensory Thresholds; Smell; Young Adult | 2014 |
Ligustilide prevents cognitive impairment and attenuates neurotoxicity in D-galactose induced aging mice brain.
Topics: 4-Butyrolactone; Aging; Animals; Brain; Cognition Disorders; Galactose; GAP-43 Protein; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Male; Malondialdehyde; Maze Learning; Mice; Mice, Inbred ICR; Neuroprotective Agents; Neurotoxicity Syndromes; Sodium-Potassium-Exchanging ATPase; Statistics, Nonparametric | 2015 |
An incident case-referent study on plasma enterolactone and breast cancer risk.
Topics: 4-Butyrolactone; Aging; Breast Neoplasms; Cohort Studies; Dietary Fiber; Female; Humans; Lignans; Reference Values; Risk Factors; Surveys and Questionnaires | 2002 |
Decreased catalepsy response to haloperidol in the genetically dystonic (dt) rat.
Topics: 4-Butyrolactone; Aging; Animals; Brain; Catalepsy; Corpus Striatum; Dopamine; Dystonia; Golgi Apparatus; Haloperidol; Humans; Morphine; Neurons; Rats; Rats, Mutant Strains; Receptors, Muscarinic; Species Specificity | 1984 |
Differential functional ontogeny of dopamine presynaptic receptor regulation.
Topics: 4-Butyrolactone; Aging; Animals; Corpus Striatum; Dopamine; Female; Male; Neural Inhibition; Olfactory Bulb; Rats; Receptors, Dopamine; Synapses | 1981 |
Phyto-oestrogen excretion and rate of bone loss in postmenopausal women.
Topics: 4-Butyrolactone; Aging; Bone Density; Chromans; Equol; Estrogens, Non-Steroidal; Female; Gas Chromatography-Mass Spectrometry; Genistein; Humans; Isoflavones; Lignans; Linear Models; Middle Aged; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Postmenopause; Prospective Studies; Time Factors | 1998 |
Relationships of urinary phyto-oestrogen excretion to BMD in postmenopausal women.
Topics: 4-Butyrolactone; Aged; Aging; Apigenin; Body Mass Index; Bone Density; Estrogens, Non-Steroidal; Female; Femur Neck; Flavonoids; Gas Chromatography-Mass Spectrometry; Humans; Isoflavones; Lignans; Lumbar Vertebrae; Middle Aged; Phytoestrogens; Plant Preparations; Postmenopause; Regression Analysis | 2002 |
Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.
Topics: 4-Butyrolactone; Aging; Animals; Body Weight; Corpus Striatum; Dopamine; Female; Haloperidol; Limbic System; Male; Nucleus Accumbens; Olfactory Bulb; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sex Factors | 1985 |